Biotech Investing SECRETS: Start Your New Year 2022 Right!
Summary
- I share with you secrets on getting the most out of 2022.
- You should focus on the few not the many.
- Increase your resolution and specialization in one niche.
In less than four hours, you're heading into New Year 2022.
That being said, I wish you a Happy New Year!
May 2022 brings you much health, wealth, and happiness!
Now, if you want to "level up" this year as I do, read on.
If you don't care, just close the article. You won't offend me.
As you pursue happiness and success, there is one BIG secret that I want to share with you.
That is to say, you should focus on the few rather than the many.
Specifically, you should NOT chase multiple industries.
Even researching biotech for over a decade, there are still much more I haven't learned.
In the stock market (as well as in life), you will make more money (and achieve more success) by SPECIALIZATION.
After all, specialization helps you to develop EXPERTISE.
With expertise comes MONEY.
As such, you'll be able to buy Ferraris, Porches, and Roll Royces.
Your life is too short.
Start making it count in 2022.
If your enemies are living in luxury, why not you?
Let's say you decided to specialize in biotech going forward.
But you then learn that bio-stocks are much more volatile.
As a result, you're tempted to buy other types of stocks.
If that occurs, you need to remind yourself that in a bear market,
growth bio-stocks usually fall faster than blue-chip equity or REITs.
Overcome your FEAR!
Instead of thinning your focus, average down on biotech for the big win in the long run.
You won't regret chasing shiny object syndrome.
If you enjoy reading my message, check out my private investing community, i.e., IBI.
Inside IBI, we uncover big winners like CryoPort (CYRX), BioLife (BLFS), Intra-Cellular Therapies (ITCI), TG Therapeutics (TGTX), Vanda Pharmaceuticals (VNDA), and many more.
At IBI: Everyone is getting smarter. Everyone is respected. You don't feel like a fool. And you’re a part of something bigger than yourself.
Inside IBI, we stay ahead of the market!
I'm so confident in the value of my service that I'm giving you a 2-week FREE trial, money-back guarantee.
GET YOUR FREE GIFT TO PROFITABILITY NOW!
Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours.
As a medical doctor/market expert, I'm not a registered investment advisor. Despite that I strive to provide the most accurate information, I neither guarantee the accuracy nor timeliness. Past performance does NOT guarantee future results. I reserve the right to make any investment decision for myself and my affiliates pertaining to any security without notification except where it is required by law. I'm also NOT responsible for the action of my affiliates. The thesis that I presented may change anytime due to the changing nature of information itself. Investing in stocks and options can result in a loss of capital. The information presented should NOT be construed as recommendations to buy or sell any form of security. My articles are best utilized as educational and informational materials to assist investors in your own due diligence process. That said, you are expected to perform your own due diligence and take responsibility for your action. You should also consult with your own financial advisor for specific guidance, as financial circumstances are individualized. That aside, I'm not giving you professional medical advice. Before embarking on any health-changing behavior, make sure you consult with your own doctor.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.